CDC committee to decide on recommendation for J&J vaccine today

(Photo by lechatnoir/Getty Images)(Image by lechatnoir/Getty Visuals)

The Facilities for Disorder Handle and Prevention Advisory Committee on Immunization Methods is expected to vote today on its suggestion for use of the Johnson & Johnson vaccine.

The committee meets from 11 a.m. to 5 p.m. today in a meeting open up to the public by weblink, with a half hour on the agenda open up for public comment.

Use of the Johnson & Johnson vaccine is presently on pause in all fifty states centered on the former suggestion of the committee. 6 females produced blood clots six to thirteen days immediately after acquiring the vaccine.

The CDC released an investigation immediately after an Oregon lady in her 50s produced a blood clot and died in two months of acquiring the Johnson & Johnson COVID-19 vaccine, according to OPD. There has nevertheless to be a dedication that the vaccine brought on her loss of life.

Present-day meeting features a possibility/advantage evaluation of use of the vaccine. J&J’s chief clinical officer as perfectly as the World Head of Janssen Study and Progress will attend, according to the day’s agenda.

WHY THIS Matters

A source has advised CBS News that the Facilities for Disorder Handle and Prevention and the Foodstuff and Drug Administration are leaning toward resuming use of the Johnson & Johnson vaccine with a warning about blood clots.

On the other hand, it is really use is coming at a tipping position in which vaccine supply will quickly outstrip need in the United States because of to vaccine hesitancy on the element of people who have nevertheless to get a shot.

THE Larger sized Trend

Additional than 6.eight million doses of the J&J vaccine have been administered.

These adverse occasions show up to be extremely scarce, according to Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter Marks, director of the FDA’s Heart for Biologics Evaluation and Study. 

On April thirteen, the advisory committee recommended pausing the vaccine as it reviewed the knowledge of the adverse occasions.

Twitter: @SusanJMorse
E-mail the writer: [email protected]